Cas:610-04-8 3-formylsalicylic acid manufacturer & supplier

We serve Chemical Name:3-formylsalicylic acid CAS:610-04-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-formylsalicylic acid

Chemical Name:3-formylsalicylic acid
CAS.NO:610-04-8
Synonyms:3-formyl-2-hydroxybenzoic acid;3-carboxyl-2-hydroxybenzaldehyde;2-hydroxy-3-carboxybenzaldehyde;2-hydroxy-3-formylbenzoic acid;3-Carboxy-2-hydroxybenzaldehyde;2-Hydroxyisophthalaldehydic acid
Molecular Formula:C8H6O4
Molecular Weight:166.13100
HS Code:2918990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:306.9ºC at 760 mmHg
Density:1.482g/cm3
Index of Refraction:1.669
PSA:74.60000
Exact Mass:166.02700
LogP:0.90290

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-formyl-2-hydroxybenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Hydroxyisophthalaldehydic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Hydroxyisophthalaldehydic acid Use and application,2-Hydroxyisophthalaldehydic acid technical grade,usp/ep/jp grade.


Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved. 3-formylsalicylic acid manufacturer Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday. 3-formylsalicylic acid supplier This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved. 3-formylsalicylic acid vendor Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. 3-formylsalicylic acid factory A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory.